Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:I-242-I-248
doi: 10.1161/CIRCULATIONAHA.104.526152
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikonomidis, J. S.
Right arrow Articles by Spinale, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikonomidis, J. S.
Right arrow Articles by Spinale, F. G.
Related Collections
Right arrow Animal models of human disease
Right arrow CV surgery: aortic and vascular disease
Right arrow Other Vascular biology

(Circulation. 2005;112:I-242 – I-248.)
© 2005 American Heart Association, Inc.


Myocardial Protection and Vascular Biology

Effects of Deletion of the Matrix Metalloproteinase 9 Gene on Development of Murine Thoracic Aortic Aneurysms

John S. Ikonomidis, MD, PhD; John R. Barbour, MD; Zainab Amani; Robert E. Stroud, MS; Amanda R. Herron, BS; David M. McClister, Jr, BS; Sarah E. Camens, BS; Merry L. Lindsey, PhD; Rupak Mukherjee, PhD; Francis G. Spinale, MD, PhD

From the Cardiothoracic Surgical Research, Division of Cardiothoracic Surgery, Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center (J.S.I., F.G.S.), Charleston, SC.

Correspondence to Dr John S. Ikonomidis, Division of Cardiothoracic Surgery, Medical University of South Carolina, Suite 409 CSB, 96 Jonathan Lucas St, Charleston, SC, 29425. E-mail ikonomij{at}musc.edu

Background— The matrix metalloproteinases (MMPs) contribute to cardiovascular remodeling, and MMPs, such as the gelatinases (MMP-9 and MMP-2), have been identified in thoracic aortic aneurysmal (TAA) tissue, but a cause-effect relationship has not been clearly established. Accordingly, this study examined TAA progression in mice devoid of the MMP-9 gene.

Methods and Results— The descending thoracic aortas of wild-type (WT) FVB (n =17) and MMP-9 gene knockout (KO, n =11) mice were exposed to 0.5 mol/L of CaCl2 for 15 minutes with terminal studies performed at 4 weeks. Aortic lumen diameter was measured using video micrometry at baseline and at 4 weeks (TAA) followed by aortic tissue analysis. In WT mice, aortic diameter increased by 138±5% at 4 weeks (P<0.05), consistent with TAA formation. In the KO mice, aortic diameter increased from baseline by 120±4% (P<0.05) but was attenuated from WT TAA values (P<0.05). Gelatin zymography performed on TAA segments confirmed the absence of MMP-9 in the KO mice but a >8-fold relative increase in the active form of MMP-2 compared with WT (P<0.05). Despite this, MMP-2 activity was relatively increased (P<0.05) and colocalized to smooth muscle cell actin in a differential pattern favoring medial distruction in the WT TAA compared with the KO TAA segments.

Conclusions— These results demonstrate that MMP-9 gene deletion attenuated TAA formation despite an increase in the zymographic levels of MMP-2. These unique findings suggest that an interaction between these 2 MMPs is necessary to facilitate TAA progression.


Key Words: aneurysm • aorta • thorax • MMP-9 • MMP-2